UroGen Pharma Ltd. (URGN)
NGM – Real Time Price. Currency in USD
48.77
+1.66 (3.52%)
Market open: Aug 12, 2026, 2:28 PM EDT
47.13
+0.02 (0.04%)
Previous after-hours: Aug 11, 2026, 7:36 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
48.77
+1.66 (3.52%)
Market open: Aug 12, 2026, 2:28 PM EDT
47.13
+0.02 (0.04%)
Previous after-hours: Aug 11, 2026, 7:36 PM EDT
No Data
There are no news for this stock.
Total debt $196.1M significantly exceeds cash reserves ($80.5M), raising financial stability concerns
Total current assets $235.4M exceed Total current liabilities $61.9M, highlighting excellent liquidity
Debt-to-equity ratio (-1.5) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (0.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$35.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.80 | 6.05 | 10 | |
| Quick ratio | 3.41 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.78 | 1.04 | 2.0 | |
| Interest coverage | 0.01 | -16.91 | 2.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 64M | 83M | 90M | 110M | 189M |
| Gross Profit | 57M | 73M | 82M | 97M | 171M |
| Operating Income | -79M | -66M | -97M | -125M | -67M |
| Net Income | -110M | -102M | -127M | -153M | -98M |
| EBITDA | -77M | -64M | -96M | -122M | -64M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 229.62 | 114.77 | 10 |
| Next quarter | 186.03 | 174.11 | 10 |
| Current year | 193.45 | 93 | 10 |
| Next year | 68.06 | 1457.4 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 42.18 | 39.12 | 40.43 | 22.68 | 10 |
| Y/Y | 199.22 | 71.26 | 73.33 | 12.98 | 9.5 |
| 3y average | 19.75 | -12.72 | 11.58 | -27.19 | 4.5 |
| 5y average | 80.08 | -4.69 | 10.82 | -12.81 | 4.8 |
| Weighted average score | 7.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |